findmyKOL

Randall Zusman, MD

Enriched profile

Director, Division of Hypertension, Massachusetts General Hospital Heart Center; Associate Professor of Medicine, Harvard Medical School · Massachusetts General Hospital

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusHypertension
Active KOLfindmyKOL type: EliteLatest publication2012Online presenceNone verifiedPayments2021–2025NIH funding1985–1985Why? →

Randall Zusman is Director, Division of Hypertension, Massachusetts General Hospital Heart Center; Associate Professor of Medicine, Harvard Medical School at Massachusetts General Hospital. ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 16 Oct 2026

Randall Zusman, MD, is Director, Division of Hypertension, Massachusetts General Hospital Heart Center. The public record shows 101 publications with 6,929 citations (h-index 38), centered on Hypertension. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 4 companies, 2 NIH-funded awards (1985–1985).

  • Top research focus: Hypertension
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 4 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hypertension1 trial

Research focus

OpenAlex concept fingerprint
Hypertension

Drugs & molecules

across trials, industry payments and publications
Eliquisgeneric · ApixabanClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trials—Industry payments15E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments3Recor Medical IncClinical trials—Industry payments2Kyowa Kirin Co., LtdClinical trials—Industry payments1Massachusetts General HospitalClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
38h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
4companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1985–1985

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    89.3%
    Calcium channel blocker15.9%
    Amlodipine Besylate80%Diltiazem 24hr Er (Cd)13%Amlodipine-Valsartan3%Felodipine Er2%Verapamil Er1%Nifedipine Er1%
    Part D<11 patients
    Statin15.7%
    Atorvastatin Calcium54%Rosuvastatin Calcium30%Pravastatin Sodium8%Simvastatin8%Lovastatin1%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    6.8%
    Factor Xa inhibitor4.4%
    Eliquis88%Xarelto12%
    Part D<11 patients
    P2Y12 inhibitor2%
    Clopidogrel100%
    Part D≥38 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    1.5%
    Potassium supplement1.3%
    Potassium Chloride61%Klor-Con M2039%
    Part D<11 patients
    Biguanide (metformin)0.2%
    Metformin Hcl100%
    Part D<11 patients
All 7 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)48% facility · 52% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

2 NIH research awards on record, funded 1985–1985 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Yale University School of Medicine (elected to Alpha Omega Alpha)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
  • Specialist in Clinical Hypertension

    American Society of Hypertension

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
  • Member

    American Heart Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
  • Member

    American Society of Hypertension

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
  • Member

    American Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗

Awards & honors

honors on the public record
  • Elected to Alpha Omega Alpha

    Yale University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗

Secondary affiliations

appointments beyond the home institution
  • Associate Professor of Medicine

    Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
  • Consultant in Cardiology

    Massachusetts Institute of Technology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.